Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

Go back to Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

Marinus Pharma (MRNS) Tops Q1 EPS by 31c

May 12, 2022 4:45 PM EDT

Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.52), $0.31 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $14.19 million versus the consensus estimate of $2.28 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

... More